4Kim DS, Han BH, Lee SK, et al. Evidence for selection of 11 amino acid CDR3 domains in V kappa Ⅲ-derived immunoglobulin light chains in Kawasaki disease [ J ]. Scand J Rhematol, 1997,26 (5) : 350-354.
5Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan [J]. Pediatrics ,2001,107(3) :E33.
6Han RK, Sinclair B, Newman A, et al. Recognition and management of Kawasaki disease [J ]. CMAJ,2000,162 (6) :807-812.
7Council on Cardiovascular Disease in the Young;Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease, American Heart Association. Diagnostic guidelines for Kawasaki disease [ J ]. Circulation, 2001,103 (2) : 335 - 336.
8Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young, American Heart Association [J]. Circulation,2004,114 (6) : 1708-1733.
9Genizi J, Miron D, Spiegel R, et al. Kawasaki disease in very young infants : high prevalence of atypical presentation and coronary arteritis [J ]. Clin Pediatr (Phila),2003,42 (3) : 263-267.
10Harada K. Intravenous gamma-globulin treatment in Kawasaki disease [J]. Acta Pediatr Jpn, 1991,33(6) :805-810.
